
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Karl D. Lewis, Wolfram Samlowski, John Ward, Joseph Catlett, Lee Cranmer, John Kirkwood, David Lawson, Eric Whitman, Rene GonzalezVolume:
29
Langue:
english
Pages:
6
DOI:
10.1007/s10637-009-9333-6
Date:
February, 2011
Fichier:
PDF, 131 KB
english, 2011